EDGAR Filing Documents for 0001144204-06-042440

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-06-042440

Filing Date

2006-10-16

Accepted

2006-10-16 16:42:35

Documents

Period of Report

2006-07-31

Document Format Files

Seq	Description	Document	Type	Size
1		v054867_10k.htm	10-K	6498640
2		v054867_ex4-26.htm	EX-4.26	115503
3		v054867_ex4-31.htm	EX-4.31	184604
4		v054867_ex4-32.htm	EX-4.32	113976
5		v054867_ex10-25.htm	EX-10.25	215605
6		v054867_ex10-26.htm	EX-10.26	57192
7	GRAPHIC	cardinalhealth.jpg	GRAPHIC	4413
8		v054867_ex10-27.htm	EX-10.27	190455
9		v054867_ex21.htm	EX-21	6724
10		v054867_ex23-1.htm	EX-23.1	3605
11		v054867_ex23-2.htm	EX-23.2	3365
12		v054867_ex31-1.htm	EX-31.1	22411
13		v054867_ex31-2.htm	EX-31.2	22341
14		v054867_ex32.htm	EX-32	8116
	Complete submission text file	0001144204-06-042440.txt		7450213

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)